Funding
Pre-Seed · Biotech

Claryx raises $3.5M pre-seed round

Claryx raised $3.5 million in pre-seed financing announced in August.

Updated Oct 16, 2026By RoundOS Funding desk

Outlander VC, Company Ventures, Boost VC, Neon, Mana Ventures, 640 Oxford and Precursor are among its backers.

The company uses genomic surveillance to identify hospital infection outbreaks and their sources.

Funding history

Pre-Seed · This round$3.5M

Sources

  1. Claryxprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related